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Abstract 
Polybrominated diphenyl ethers (PBDEs) are added to plastics, polyurethane foam, and textiles as a ﬂame retardant. While PBDEs play a key role 
in reducing loss of human life and property from ﬁres, these ﬂame retardants have become pervasive organic contaminants in the environment and in 
the tissues of ﬁsh, birds, marine mammals, and humans. Levels of PBDEs in wildlife and humans continue to rise, raising concerns about potential 
ecological and health risks associated with exposure to these chemicals. Nevertheless, there is little currently known about the toxicological effects 
of PBDE exposure. Here, we examined the developmental toxicity of the PBDE congener 2,2',4,4'-tetrabromodiphenyl ether (PBDE 47) using 
the zebraﬁsh (Danio rerio) as an ontogenetic model. Zebraﬁsh embryos were exposed continuously to dissolved phase PBDE 47 (100–5000 fg/l) 
beginning 3–5 h post-fertilization (hpf). Fish treated with the highest concentrations of PBDE 47 delayed hatching, had reduced growth post-
hatching, and displayed an abnormal dorsal curvature of the body with ﬂexion at the hindbrain. By 96 h post-fertilization larvae exposed to PBDE 
47 had signiﬁcant tachycardia, which progressed into atrioventricular block arrhythmias. Microinjection of ﬂuorescent dye into the hindbrain 
ventricle revealed that cerebrospinal ﬂuid in the neural tube and brain ventricles ﬂowed more slowly in ﬁsh larvae exposed to PBDE 47, a likely 
etiology for the dorsal curvature. Similar, though much less pronounced, developmental toxicity also occurred in larvae exposed to PBDE 47 only 
for a 20 h period during early embryogenesis (3–23 hpf), suggesting that PBDEs incorporated in lipid of the egg are bioavailable and cause toxicity 
later in life. Taken together, this work indicates that exposure to PBDE 47 can cause morphological abnormalities, impair cardiovascular function 
and cerebrospinal ﬂuid ﬂow, and provides a tractable starting point for using the zebraﬁsh model to explore molecular mechanisms of PBDE toxicity. 
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1. Introduction 
Polybrominated diphenyl ethers (PBDEs) are a group of 
brominated hydrocarbons used as a ﬂame retardant additive 
in plastics, textiles, polyurethane foam, and other materials. 
PBDEs are generally added to products as three commercial 
mixtures (penta-BDE, octa-BDE, or deca-BDE mixtures), each 
of which contains different proportions of the 209 possible 
PBDE congeners that vary in their degree of bromination (Alaee 
et al., 2003). While the use of PBDEs in consumer prod­
ucts has helped reduce the loss of property and human life to 
ﬁre, concerns have arisen recently about possible health risks 
associated with PBDE exposure. These concerns stem from 
accumulating evidence that levels of these persistent organic 
contaminants in the environment are rising (McDonald, 2002; 
Hites, 2004). 
PBDEs can be transported by air and water to locations far 
from their source (Wania and Dugani, 2003), and PBDE contam­
ination has now been documented in environments worldwide. 
This distribution includes even remote locations such as the deep 
ocean and the Arctic (De Boer et al., 1998; Ikonomou et al., 2002; 
Hale et al., 2003). PBDEs in the environment are bioavailable for 
uptake by organisms (Ciparis and Hale, 2005), and recent studies 
have established that PBDEs are present in the tissues of inver­
tebrates, ﬁsh, birds, and marine mammals (Bayen et al., 2003; 
F¨ om et al., 2005; Johnson-Restrepo et al., 2005; Domingo angstr¨
et al., 2006; Ikonomou et al., 2006; for review see Hites, 2004). 
PBDEs have even been detected in ﬁshes and marine mammals 
that feed in offshore waters (De Boer et al., 1998; Ueno et al., 
2004), indicating that these chemicals have become incorporated 
into pelagic and deep-sea food webs. PBDEs have also been 
found in the breast milk, blood and other tissues of humans 
(Schecter et al., 2003, 2005; Julander et al., 2005), signifying 
that the potential risks of PBDE contamination are not limited 
to wildlife. PBDEs are lipophilic, and congeners such as tetra-
BDE (PBDE 47) and penta-BDE (PBDE 99) can bioaccumulate 
rapidly in the lipid reservoirs of organisms. As a consequence, 
levels of these congeners can be considerably higher in body tis­
sues than in the surrounding environment. Recent evidence has 
also shown that PBDEs can be converted metabolically from 
one congener to another or to hydroxylated forms not originally 
included in the commercial mixtures (Kierkegaard et al., 1999; 
Stapleton et al., 2004a,b; Tomy et al., 2004; He et al., 2006). 
With the heavy production and use of consumer products con­
taining PBDEs, levels of PBDEs in wildlife and in humans in 
many parts of the world continue to rise (Ikonomou et al., 2002; 
Law et al., 2003; Rayne et al., 2003; Hites, 2004; Schecter et al., 
2005; de Wit et al., 2006), elevating concerns about the poten­
tial ecological and human health risks associated with PBDE 
exposure (Darnerud et al., 2001; McDonald, 2002; Birnbaum 
and Staskal, 2004). 
The present study explored the potential developmental tox­
icity of PBDEs using zebraﬁsh (Danio rerio) as a model. The 
fundamental aspects of zebraﬁsh development have been the 
focus of intensive research over the past decade. With this base of 
knowledge, zebraﬁsh are proving increasingly useful for investi­
gating mechanisms of chemical toxicity during early life stages 
(Hill et al., 2005; Hinton et al., 2005). Zebraﬁsh embryos and 
larvae are mostly transparent, which allows for rapid and high-
throughput screens for developmental abnormalities. Typically, 
zebraﬁsh embryos are exposed to chemical contaminants, often 
at high concentrations, to induce clear phenotypic effects that 
point to physiological and molecular pathways of toxicity. This 
strategy has recently been used to identify novel mechanisms of 
toxicity in ﬁsh exposed to dioxins (Bello et al., 2004), polycyclic 
aromatic hydrocarbons (Incardona et al., 2005), current use pes­
ticides (Haendel et al., 2004; Stehr et al., 2006) and heavy metals 
(Linbo et al., 2006). Here, we used a similar approach to investi­
gate the developmental toxicity of 2,2',4,4'-tetrabromodiphenyl 
ether (PBDE 47), commonly the most concentrated PBDE con­
gener found in the tissues of wildlife and humans (Hale et al., 
2001; Schecter et al., 2003; Brown et al., 2006; for review, see 
Hites, 2004). In ﬁsh, PBDEs may be transferred maternally in 
the lipid stores of oocytes, and offspring could be exposed to 
these compounds during the earliest stages of embryogenesis. 
However, potential mechanisms underlying the developmental 
toxicity of PBDE 47 are still poorly understood. The zebraﬁsh 
experimental system allowed us to screen for adverse responses 
to a common PBDE congener that is an increasing concern for 
the early life stages of freshwater and marine ﬁshes worldwide. 
2. Materials and methods 
2.1. Animals 
Wild-type (AB strain) and nacre strain zebraﬁsh were main­
tained in a breeding colony at the Northwest Fisheries Science 
Center (Seattle, WA, USA) according to standard zebraﬁsh 
breeding protocols (Westerﬁeld, 1995). Adults were maintained 
at 26 ◦C under a 14L:10D photoperiod in a closed ﬂow-through 
system. Water supplied to the system was ﬁltered by reverse 
osmosis (pH 7.5–8), and Instant Ocean® salt was added to the 
water to raise the conductivity to ∼1500 fS/cm (system water). 
Zebraﬁsh embryos were obtained by spawning adults in groups 
containing three females and two males overnight in spawn­
ing tanks. Eggs were collected and rinsed brieﬂy with system 
water. Fertilized eggs were then staged under a stereomicroscope 
according to the descriptions of Kimmel et al. (1995). 
2.2. PBDE treatments 
We obtained 2,2',4,4'-tetrabromodiphenyl ether (PBDE 47, 
purity >99%) from ChemService, Inc. (West Chester, PA, USA). 
A stock solution of PBDE 47 was prepared by dissolving 
0.0165 g of PBDE 47 in 10 ml of dimethyl sulfoxide (DMSO, 
Sigma). This stock solution was then diluted in system water to 
create a graded series of PBDE 47 solutions. Larval zebraﬁsh 
were exposed to PBDE 47 at concentrations calculated from 
100 to 5000 fg/l in system water with 0.3% DMSO. The con­
trol exposure consisted of system water containing 0.3% DMSO 
only. 
Zebraﬁsh embryos were 3–5 h post-fertilization (hpf) of age 
when assigned to experimental treatments, and were exposed 
to PBDE 47 or control treatments until 168 hpf. For all exper­
iments, embryos and larvae were maintained at 28.5 ◦C and 
reared in sterile 24 well plates (Corning International, Corn­
ing, NY, USA) at a density of four ﬁsh per 3 ml well. Treatment 
solutions were changed in the wells every 48 h. 
2.3. Quantiﬁcation of PBDE 47 in larval tissues 
We used gas chromatography with electron capture detection 
(GC-ECD) to determine the concentration of PBDE 47 present 
in whole-body tissues of larval zebraﬁsh from the aqueous treat­
ments described above. From 3 to 5 hpf of age, larval zebraﬁsh 
were reared in system water containing PBDE 47 (100, 500, or 
5000 fg/l) or control water (system water with 0.3% DMSO) in 
24 well plates with four larvae per 3 ml well. Water was changed 
in all wells at 48 hpf. When larvae reached 96 hpf, they were 
euthanized in MS222 dissolved in system water (250 fg/ml, 
tricaine methanesulfonate; Argent Chemical Laboratories, Red­
mond, WA) and then rinsed brieﬂy in clean system water. Larvae 
were then weighed in groups of ∼30 individuals (range, 22–37 
individuals) so that the total tissue mass of each sample was 
6.6 ± 0.4 mg (mean ± S.E.). These samples (n = 4 groups of 
larvae per treatment) were then frozen immediately in liquid 
nitrogen and stored at −80 ◦C. 
To quantify tissue levels of PBDE 47, the pooled zebraﬁsh 
larvae were homogenized in deionized water and spiked with 
20 fl of a 240 ng/ml solution of polycholorinated biphenyl 103 
(PCB 103, w/v in hexane; purchased from Sigma–Aldrich, St. 
Louis MO) as an internal standard. Hexane (1 ml) was then 
added, and the homogenate was vortexed for 30 s and centrifuged 
at 3000 × g for 5 min. The hexane layer was transferred to a 
GC-ECD autosampler vial and diluted 1:10 with hexane. The 
extraction efﬁciency of PBDE 47 was typically 90–95%. The 
hexane extracts were then analyzed on a Hewlett-Packard 5890 
GC equipped with a DB-5 30-m, 0.25 fM capillary column. 
The GC was operated in split injection mode with a split ratio 
of 8:1. The speciﬁc chromatographic conditions were as fol­
lows: injection port temperature of 250 ◦C; detector temperature 
of 300 ◦C; initial oven temperature of 90 ◦C and then raised to 
250 ◦C at 20  ◦C/min, then raised to 280 ◦C at 5  ◦C/min and held 
for three additional minutes. Under these separation conditions, 
the retention time of PBDE 47 was 12.16 min and PCB 103 was 
8.75 min. Standard curves prepared for PBDE 47 ranged from 
concentrations of 0 to 1.51 fg. 
2.4. Effects of PBDE 47 on hatching, morphological 
development, and survival 
To determine whether exposure to PBDE 47 affected the tim­
ing of hatching for zebraﬁsh, we recorded the percentage of 
embryos that emerged from the chorion in each treatment well 
at 48, 56, and 72 hpf. Hatching rates were calculated as the per­
centage of embryos that had hatched per plate well (with four 
embryos per well). Wells were replicated 24 times for each expo­
sure treatment to give ﬁnal sample sizes of n = 24 replicate wells 
per treatment. At 30 hpf, the rate of spontaneous movements 
by the embryo in the chorion was observed under a stereomi­
croscope (Nikon SMZ800) and recorded (n = 20 replicates per 
treatment). These behavioral observations were blind so that the 
observer did not have knowledge of the treatment. 
Throughout development, embryos and larvae were exam­
ined under a stereomicroscope to screen for morphological 
abnormalities and record survival rates within each treatment. 
The timing of formation of speciﬁc embryonic structures was 
compared to an established atlas for normal zebraﬁsh develop­
ment (Westerﬁeld, 1995). Fish were monitored daily from 24 
to 168 hpf. Sample sizes were n = 40 replicate rearing wells per 
treatment, with replicates for each treatment equally balanced 
across 24 well plates. 
At two points during development (72 and 96 h post­
fertilization), body length of the larval ﬁsh was measured to 
determine whether PBDE 47 exposure altered growth. Zebraﬁsh 
were anesthetized in MS222 and photographed with a digital 
camera (Spot RT camera with Spot 3.2.6 imaging software, 
Diagnostic Instruments, Inc., Sterling Heights, MI) attached to 
a stereomicroscope (Nikon SMZ800). The length of each ﬁsh 
along the body axis from the rostrum to the base of the tail was 
measured from these digital images using ImageJ software (ver­
sion 1.33, National Institutes of Health, USA). Values for body 
length are presented as mean body length per well. Sample sizes 
were n = 24 replicate wells per treatment. 
2.5. Effects of PBDE 47 on cardiac function 
We quantiﬁed cardiac beat rate to determine whether expo­
sure to PBDE 47 affected cardiac function in larval zebraﬁsh. 
Larvae were exposed to PBDE 47 at 0, 500, or 5000 fg/l begin­
ning at 3 hpf. When ﬁsh reached 72 hpf, a subset of the larvae 
were lightly anesthetized in MS222 (250 fg/ml) and mounted 
in 3% methyl cellulose (Sigma, St. Louis, MO, USA) on glass 
slides. Videos of the heart were recorded via a digital camera 
(Fire i400, Unibrain, San Ramon, CA, USA) attached to a bright-
ﬁeld Nikon E600 compound microscope. Beat rates for both 
the atrium and ventricle were later quantiﬁed from these digital 
videos by a blind observer using BTV Pro Carbon 5.4.1 soft­
ware. Sample sizes were n = 10–11 ﬁsh for all treatments and 
developmental ages except for the highest dose of PBDE 47 
(5000 fg/l) at 168 hpf. Larvae in the 5000 fg/l PBDE 47 treat­
ment experienced high mortality by this age (see Section 3), so 
only the few surviving ﬁsh (n = 2) could be sampled. 
2.6. Imaging of cerebrospinal ﬂuid ﬂow in the neural tube 
and brain ventricles 
We spawned adult zebraﬁsh of the reduced-pigment nacre 
strain following the protocol described above, and reared the 
embryos in 5000 fg/l PBDE 47 (n = 15) or 0.3% DMSO con­
trol (n = 14) solutions in 24 well plates with four ﬁsh per well. 
At 144 hpf, the larvae were lightly anesthetized in MS222 
(250 fg/ml) and mounted in 2% low melt agarose (LMP Ultra-
Pure agarose, Invitrogen Corp., Carlsbad, CA, USA). The 
hindbrain ventricle was microinjected dorsally with a 5% solu­
tion of dextran dye containing tetramethylrhodamine (70,000 
MW; Molecular Probes, Inc., Eugene, OR, USA) according to 
methods described by Lowery and Sive (2005). The ﬂuorescent 
dye was allowed to distribute throughout the brain ventricles and 
down the neural tube for 20 min, at which time we quantiﬁed 
the distance down the neural tube that the dye had traveled. This 
distance was measured by counting the number of segmented 
skeletal muscle myotomes passed by the ﬂuorescent dye in the 
neural tube. At this time, we also captured lateral ﬂuorescent 
photomicrographs of the brain using a digital camera (Fire i400, 
Unibrain, San Ramon, CA) mounted on a Nikon E600 micro­
scope to document the dispersion of dye from the hindbrain 
ventricle forward into the forebrain and midbrain ventricles. Lar­
vae were then quickly ﬁxed in 4% paraformaldehyde, rinsed in 
phosphate buffered saline (0.1 M), and imaged dorsally using a 
confocal laser-scanning microscope (LSM 5 Pascal, Carl Zeiss, 
Inc., Oberkochen, Germany). 
2.7. Effects of early pulse exposures to PBDE 47 
To test whether transient exposure to PBDE 47 during early 
embryogenesis is sufﬁcient to cause developmental disorders, 
zebraﬁsh embryos were exposed to PBDE 47 for a 20 h interval 
beginning at 3 hpf. Embryos were exposed to aqueous solutions 
of PBDE 47 at 100, 500, or 5000 fg/l or a vehicle control solu­
tion (0.3% DMSO) in 24 well plates. After 20 h of exposure, 
embryos from all treatments were removed from the PBDE 47 
and control solutions, rinsed in system water for 1 min over a 
plastic screen, and transferred to clean system water in new 24 
well plates. The clean water was then changed every 48 h in each 
well. At 168 hpf, larvae from all treatments were screened for 
developmental abnormalities. Sample sizes were n = 15 wells 
per treatment. 
2.8. Statistical analyses 
Since the hatching data failed to conform to the assumptions 
of normality, we used a Kruskal–Wallis nonparametric test to 
examine whether PBDE 47 affected the percentage of ﬁsh that 
had hatched from the chorion at 48, 56, and 72 hpf. We then 
used a Dunnett’s test to conduct pairwise comparisons between 
PBDE 47 treatments and the control (Zar, 1999). The body 
length of larvae at 72 and 96 hpf was compared among treat­
ments using one-factor analysis of variance (ANOVA) models, 
followed by Dunnett’s tests for multiple pairwise comparisons 
with the control. We used repeated-measures multiple analysis 
of variance (MANOVA) models to determine whether PBDE 47 
affected the incidence of morphological deformities, survivor-
ship, and the beat rate of the atrium and ventricle heart chambers. 
We tested for interactions between treatment and time in these 
MANOVA models using the Wilks’ lambda (Λ) test statistic. 
Within each time point, pairwise comparisons between each 
treatment and the control were made using Dunnett’s tests. The 
ﬂow rate of ﬂuorescent dextran dye down the neural tube was 
compared between PBDE 47 and control treatments using a two-
sample t test. Lastly, we used a Kruskal–Wallis nonparametric 
test to examine whether short-term (20 h) exposure to PBDE 47 
affected the frequency of morphological abnormalities, followed 
by a Dunnett’s test to conduct pairwise comparisons between the 
control groups and the PBDE 47 treatments. All statistical tests 
were two-tailed and performed using JMP 5.1 software (SAS 
Institute, Inc.). 
3. Results 
3.1. Whole-body tissue levels of PBDE 47 
Levels of PBDE 47 in whole-body tissue homogenates of 
larvae (96 hpf of age) exposed to control solution and to PBDE 
47 at 100, 500, and 5000 fg/l are provided in Table 1. Tissue 
concentrations of PBDE 47 varied among treatments as expected 
by the graded concentrations of PBDE 47 solutions. 
3.2. Exposure to PBDE 47 delays hatching and impairs 
growth 
Embryos exposed to PBDE 47 at concentrations of 2000 and 
5000 fg/l hatched later from the chorion than embryos exposed 
to the control 0.3% DMSO solution. This delay in hatching was 
signiﬁcant at 56 hpf (Table 2) but appeared to be short in dura-
Table 1 
Concentrations of PBDE 47 in whole-body tissues of zebraﬁsh (at 96 h post­
fertilization) from static-renewal exposures 
Treatment Tissue concentration 
(fg PBDE 47 per g wet wt) (fg PBDE 47 per ﬁsh) 
Control 0.00 ± 0.00 0.000 ± 0.000 
100 fg/l 3.36 ± 0.72 0.001 ± 0.000 
500 fg/l 77.54 ± 7.82 0.016 ± 0.002 
5000 fg/l 293.28 ± 21.64 0.060 ± 0.005 
Table 2 
Effects of PBDE 47 on mean (±S.E.) percent of embryos hatched at 48, 56, and 
72 h post-fertilization (hpf) 
PBDE 47 dose % embryos hatched 
48 hpf 56 hpf 72 hpf 
Control 4.2 ± 2.3 67.7 ± 4.9 96.9 ± 1.7 
100 fg/l 2.1 ± 1.4 61.5 ± 5.2 96.9 ± 1.7 
500 fg/l 3.1 ± 1.7 51.0 ± 6.1 94.8 ± 2.1 
1000 fg/l 4.2 ± 2.5 49.0 ± 7.1 96.9 ± 1.7 
2000 fg/l 6.3 ± 3.8 34.4 ± 6.5* 93.8 ± 2.7 
5000 fg/l 0.0 ± 0.0 43.7 ± 4.9* 97.9 ± 1.4 
χ2 = 3.5140, χ2 = 17.8787, χ2 = 2.6041, 
p = 0.6213 p = 0.0031 p = 0.7607 
Note: Asterisks indicate signiﬁcant difference from control (Dunnett’s test, 
p < 0.05). 
tion, as we found no effect of PBDE 47 on the proportion of 
ﬁsh hatched at either 48 hpf or 72 hpf. This temporary delay 
in hatching was not associated with any signiﬁcant develop­
mental delay of embryogenesis as ﬁsh exposed to PBDE 47 
followed normal developmental timing as described by Kimmel 
et al. (1995). Moreover, the delayed hatching seen in PBDE 47­
exposed larvae did not appear to be caused by differences in 
Fig. 1. Exposure to PBDE 47 resulted in larvae with a smaller body length at 
72 h post-fertilization (hpf) (A) and 96 hpf (B). Asterisks indicate signiﬁcant 
difference from control. Values are presented as mean ± S.E. 
the activity of embryos within the egg, since embryos exposed 
to PBDE 47 at 500 and 5000 fg/l showed no difference in 
the frequency of spontaneous movements within the chorion 
compared to control embryos (control, 0.59 ± 0.11 movements 
per min; 500 fg/l PBDE 47, 0.81 ± 0.12; 5000 fg/l PBDE 47, 
0.88 ± 0.13: F2,55 = 1.6147, p = 0.2082). 
Zebraﬁsh treated with PBDE 47, however, were smaller in 
body length shortly after hatching (Fig. 1). At 72 hpf, this reduc­
tion in body length was statistically signiﬁcant only in larvae 
exposed to PBDE 47 at exposures that also delayed hatching 
at 56 hpf (see Table 2). By 96 hpf, however, larvae exposed to 
lower concentrations of PBDE 47 (500 fg/l and greater) were 
also smaller in body size compared to controls. 
3.3. PBDE 47 causes developmental defects and larval 
mortality 
Larvae exposed to PBDE 47 showed a consistent and 
highly repeatable suite of morphological deformations. These 
abnormalities included the development of an abnormal dor­
sal curvature of the trunk and tail which ﬁrst appeared at 
72 hpf at the highest exposure concentration and became more 
pronounced over the next few days of larval development 
(Fig. 2). This trunk curvature occurred in ∼100% of the lar­
vae exposed to PBDE 47 at aqueous solutions of 400 fg/l or 
greater (Fig. 3). However, the temporal onset of this abnor­
mality was dose-dependent, with trunk malformation appearing 
Fig. 2. Exposure to PBDE 47 (5000 fg/l) caused morphological abnormalities including the development of a dorsally curved tail and the failed inﬂation of the 
swim bladder. Lateral view of control (A) and PBDE 47-exposed (B) larvae at 96 h post-fertilization (hpf). Lateral view of control (C and E) and PBDE 47-exposed 
(D and F) larvae at 164 hpf. Higher magniﬁcation views in E and F show the failed inﬂation of the swim bladder and an unusually dark liver (arrows) and a ﬂexion 
at the hindbrain (asterisk) in PBDE 47-exposed ﬁsh. Scale bars = 1mm  (A–D) and 500 fm (E and F). 
Fig. 3. The frequency of abnormal dorsal tail curvature plotted against larval age 
in hours post-fertilization (hpf). The occurrence of this dorsal tail curvature was 
dose-dependent (treatment effect, F8,275 = 13.3271, p < 0.0001). All exposures 
began at 3–5 hpf and were renewed every 48 h until larvae were 172 hpf of age. 
Values are presented as mean ± S.E. 
later for ﬁsh exposed to PBDE 47 at the lower concen­
trations (treatment effect, F8,275 = 13.3271, p < 0.0001; time 
effect, F4,272 = 21.8288, p < 0.0001; treatment × time interac­
tion, Wilks’ Λ, F32,1005 = 62.0006, p < 0.0001). We did not, 
however, observe any corresponding edema of the eyes or peri­
cardial cavity in larvae exhibiting this tail curvature, as has 
been observed in several recent studies of toxicant-induced body 
axis defects in zebraﬁsh larvae (i.e., Blechinger et al., 2002; 
Incardona et al., 2004; Lefebvre et al., 2004). 
At the upper range of PBDE 47 exposures (400–5000 fg/l), 
dorsal tail curvature was often accompanied by additional 
developmental abnormalities. These changes included a fail­
ure of the swim bladder to inﬂate, a discoloration of the 
liver, and a ﬂexion of the head at the level of the hindbrain 
(Fig. 2E and F). After the development of trunk curvature, lar­
vae swam in an abnormal swirling motion. However, prior to 
the appearance of the dorsal trunk curvature, larvae showed 
unusually lethargic movement suggesting that there may be 
more subtle physiological effects of PBDE 47 exposure exhib­
ited prior to the acute morphological effects documented here. 
Exposure to PBDE 47 at 500 fg/l or higher signiﬁcantly 
reduced larval survival by 168 hpf relative to controls (Fig. 4). 
Survival was inﬂuenced by the dose of PBDE 47, with mor­
tality occurring earlier in larvae exposed to higher PBDE 
47 levels (treatment effect, F8,315 = 26.5841, p < 0.0001; time 
effect, F6,310 = 156.5638, p < 0.0001, treatment × time interac­
tion, Wilks’ Λ, F48,1529 = 15.4581, p < 0.0001). 
3.4. Exposure to PBDE 47 alters cardiac function 
Exposures to PBDE 47 at 500 and 5000 fg/l had disrup­
tive effects on cardiac function in larval zebraﬁsh. These effects 
included a signiﬁcant increase in the beat rates (tachycardia) 
of both the atrium (treatment effect, F2,19 = 1.6141, p = 0.2252; 
time effect, F4,16 = 9.1732, p = 0.0005; treatment × time inter-
Fig. 4. Exposure to PBDE 47 decreased survival. The percent survivorship 
of larvae exposed to PBDE 47 was highly dose-dependent (treatment effect, 
F8,315 = 26.5841, p < 0.0001). All PBDE 47 exposures began at 3–5 h post­
fertilization (hpf) and were renewed every 48 h. Values are presented as 
mean ± S.E. 
action, Wilks’ Λ, F8,32 = 2.6213, p = 0.0249) and ventricle 
(treatment effect, F2,19 = 2.3504, p = 0.1224; time effect, 
F4,16 = 8.6640, p = 0.0006; treatment × time interaction, Wilks’ 
Λ, F8,32 = 5.1803, p = 0.0003) (Fig. 5A). Tachycardia ﬁrst 
appeared when larvae were between 72 and 96 hpf of age 
and its extent was positively related to PBDE dose. Moreover, 
at the higher PBDE 47 exposure concentration (5000 fg/l), 
tachycardia progressed into arrhythmia by 120 hpf, as indi­
cated by a deviation in the atrium to ventricle beat ratio 
(Fig. 5B; treatment effect, F2,19 = 20.9454, p < 0.0001; time 
effect, F4,16 = 12.1178, p < 0.0001; treatment × time interaction, 
Wilks’ Λ, F8,32 = 5.5340, p = 0.0002). The observed arrhythmias 
were typically regular and represented various degrees of atri­
oventricular conduction block, i.e., atrial:ventricular beat ratios 
of 4:1, 5:1 and 8:1. 
3.5. PBDE 47 alters cerebrospinal ﬂuid movement in the 
neural tube and brain 
Live examination of PBDE 47-exposed larvae suggested 
subtle alterations in circulation of blood within the hindbrain. 
To explore the potential link between CNS hemodynamics, 
cerebrospinal ﬂuid (CSF) dynamics, and dorsal curvature, we 
assessed CSF movement after microinjection of ﬂuorescent dex­
tran dye into the hindbrain ventricle (Fig. 6A). Movement of 
CSF in the brain ventricles and central canal of the neural 
tube was reduced in larvae exposed to PBDE 47 (5000 fg/l). 
Dye in the CSF traveled signiﬁcantly slower down the cen­
tral canal in PBDE-exposed larvae compared to control ﬁsh 
(Fig. 6B; t = 4.4687, p < 0.0001). Movement of the dye from 
the hindbrain forward into the midbrain and forebrain ven­
tricles was also reduced in PBDE 47 treated ﬁsh. At 20 min 
after injection, the dye had dispersed forward into the fore­
brain ventricle in only 27% (4 of 15) of PBDE 47 larvae 
compared to 79% (11 of 14) of the controls. Taken together, 
these ﬁndings suggest that PBDE 47 exposure caused signiﬁcant 
Fig. 5. PBDE 47 elevated heart rate and induced a cardiac arrhythmia in zebraﬁsh 
larvae. (A) The atrial and ventricular rates were signiﬁcantly higher at 96 h post­
fertilization (hpf) in larvae exposed to PBDE 47. This elevated cardiac rate 
developed between 72 and 96 hpf. (B) The atrium:ventricle beat ratio plotted 
against larva age (hpf). Zebraﬁsh larvae exposed to PBDE 47 at concentrations 
of 5000 fg/l developed a cardiac arrhythmia by 144 hpf. Asterisks indicate a 
statistically signiﬁcant difference from control (Dunnett’s tests, p < 0.05). All 
PBDE 47 exposures began at 3–5 hpf and were renewed every 48 h, and values 
are presented as mean ± S.E. 
changes in CSF dynamics within the brain ventricles and neural 
tube. 
3.6. Transient embryonic exposure to PBDE 47 causes 
subsequent toxicity 
Exposure to PBDE 47 during early embryogenesis (3–23 hpf) 
caused morphological abnormalities similar to those seen in 
larvae exposed continuously to PBDE 47 (χ2 = 49.3188,0.05,5 
p < 0.0001) (Fig. 7A). The proportion of ﬁsh showing these 
abnormalities, however, was considerably reduced with only a 
20 h period of PBDE 47 exposure compared to static-renewal 
exposures. Larvae treated with PBDE 47 (at concentrations of 
500 and 5000 fg/l) for 20 h still developed an abnormal dor­
sally curved tail by 7 dpf, however this spinal curvature was less 
pronounced in even the most severely curved individuals from 
the 20 h exposure (Fig. 7B) compared to larvae from the contin­
uous static-renewal PBDE 47 exposures (see Fig. 3D). Larvae 
exposed to PBDE 47 for only 20 h also showed normal swim 
bladder inﬂation. 
4. Discussion 
Our results demonstrate that exposure to PBDE 47 during 
early life can cause developmental changes in ﬁsh including 
reduced growth, abnormal morphology, irregular cardiac func­
tion, and altered cerebrospinal ﬂuid ﬂow. These PBDE-induced 
changes were manifested early in development, with the ﬁrst 
effects of PBDE 47 exposure seen as a delay in hatching and 
a reduction in body size. Shortly after hatching, however, lar­
vae exposed to PBDE 47 began to exhibit a consistent and 
repeatable suite of morphological abnormalities that included 
the development of an abnormal dorsally curved tail. This tail 
curvature was ﬁrst seen at an age of 72 hpf in ﬁsh exposed to 
the highest doses of PBDE 47, and became more pronounced 
and common over the next several days in larvae exposed to all 
PBDE 47 doses. PBDE 47 also induced cardiac abnormalities 
and changes in cerebrospinal ﬂuid movement in zebraﬁsh lar­
vae. Cardiac changes were ﬁrst seen as tachycardia by 96 hpf, 
but progressed into atrioventricular block arrhythmias that may 
have contributed to the high mortality seen in ﬁsh exposed to 
the highest concentrations of PBDE 47. We also observed that 
larvae exposed to PBDE 47 showed reduced movement of cere­
brospinal ﬂuid in the brain ventricles and neural tube. Movement 
of cerebral spinal ﬂuid plays a key role in regulating stem cell 
proliferation and normal brain development (Owen-Lynch et 
al., 2003; Miyan et al., 2003), and reductions in cerebrospinal 
ﬂuid ﬂow have been linked to depressed neurogenesis and men­
tal retardation in rodents (Mashayekhi et al., 2002). Changes 
in cerebral spinal ﬂuid ﬂow in zebraﬁsh exposed to PBDE 47 
may thus lead to the development of neural deﬁciencies later 
in life. 
The toxic developmental effects of PBDE 47 were clearly 
dose-dependent, with higher doses of dissolved PBDE 47 mani­
festing abnormalities earlier in development. While we primarily 
reared embryos and larvae in static-renewal exposures to PBDE 
47, we also found that similar, though less pronounced, morpho­
logical abnormalities were manifest in zebraﬁsh larvae exposed 
to PBDE 47 for only a 20 h period during early life (when larvae 
were 3–23 hpf of age). Even though the embryos were reared in 
clean water for all but the ﬁrst 20 h of development, these ﬁsh still 
displayed toxicological effects of PBDE 47 exposure. PBDEs 
are highly lipophilic, and PBDE 47 may have been incorporated 
into lipid stores of the embryo during the 20 h embryonic expo­
sure. Incorporated PBDE 47 may then have been bioavailable to 
induce toxicological effects later in development. Further sup­
port for this idea comes from our preliminary observations that 
zebraﬁsh embryos exposed to PBDE 47 during other periods 
of development (24–48 or 48–72 hpf) also developed a dorsal 
tail curvature by 168 hpf (data not shown). In ﬁsh and other 
taxa, the egg can be a signiﬁcant pathway for embryonic expo­
sure to PBDEs (Petersen and Kristensen, 1998). Our results 
showing that a brief exposure to PBDE 47 during embryogene­
sis can cause morphological abnormalities suggest that PBDEs 
Fig. 6. PBDE 47 exposure alters cerebrospinal ﬂuid movement in the brain and neural tube in zebraﬁsh larvae (144 hpf). (A) Fluorescent dextran dye was microinjected 
into the hindbrain ventricle (arrow) and allowed to disseminate for 20 min into the brain ventricles and neural tube. (B) The ﬂow rate of dye down the neural tube 
was signiﬁcantly greater in control ﬁsh than in larvae exposed to PBDE 47 (5000 fg/l). Values are plotted as mean ± S.E. (C and D) Representative images taken 
dorsally of the brain ventricles 20 min after microinjection revealed that the ﬂuorescent cerebrospinal ﬂuid has ﬁlled the ventricles of the hindbrain (H), midbrain 
(M), and forebrain (F) in control larvae (C), but had not yet reached the forebrain ventricle in PBDE 47-exposed larvae (D). 
transferred maternally through the oocyte might result in devel­
opmental toxicity in ﬁsh during later life. 
4.1. Biological impacts and mechanisms of PBDE toxicity 
PBDEs are an emerging organic pollutant (Hale et al., 2001; 
McDonald, 2002; Birnbaum and Staskal, 2004), yet much 
remains unknown about the biological effects of PBDE expo­
sure. Studies from controlled PBDE exposures in the laboratory 
have shown that PBDEs can impact neural function and behav­
ior. Neonatal exposure to each of the PBDE congeners PBDE 47, 
PBDE 99, PBDE 153, and PBDE 209 has been shown to cause 
long-term behavioral abnormalities including elevated sponta­
neous behaviors and learning/memory deﬁciencies in rodents 
(Eriksson et al., 2002; Viberg et al., 2003a, 2004; Branchi et al., 
2005; Lilienthal et al., 2005). In ﬁsh, exposure to the commercial 
PBDE mixture DE-71 caused delayed hatching and alterations in 
behavior that included depressed swimming activity and feeding 
rates in larval mummichog, Fundulus heteroclitus (Timme-
Laragy et al., 2006). While behavioral changes in mummichog 
were observed at DE-71 concentrations as low as 0.001 fg/l, a 
delay in hatching was only seen at the highest DE-71 concen­
tration tested (100 fg/l). Although the mechanisms underlying 
these defects are unclear, as are the precise cellular or molec­
ular targets of PBDEs, recent studies have focused on thyroid 
hormone function and cholinergic pathways in the CNS. PBDEs 
depressed plasma levels of the thyroid hormone thyroxine (T4) 
in a variety of vertebrates including rodents (Hallgren et al., 
2001; Hallgren and Darnerud, 2002), birds (Fernie et al., 2005), 
and ﬁsh (Tomy et al., 2004). In rodents, PBDE exposure has 
also been shown to alter cholinergic functioning in neural tis­
sues (Dufault et al., 2005). Rats exposed to PBDEs had fewer 
nicotinic acetylcholine receptors in the hippocampus, possibly 
contributing to impaired learning and memory (Viberg et al., 
2002, 2003b, 2005). 
Are there potential links between these neurotoxic or 
endocrine-disrupting effects of PBDEs and our observed effects 
of PBDE 47 during zebraﬁsh development? Overall, two lines of 
evidence suggest that the most pronounced effects of PBDE 47 
described here arise from impacts on neural development. First, 
dorsal curvature of the body axis can be secondary to defects in 
cardiac function (Incardona et al., 2004, 2006), most likely due 
to the links between systemic blood pressure, CSF secretion, and 
maintenance of brain ventricle volume (Carey and Vela, 1974; 
Fig. 7. Developmental toxicity of PBDE 47 in zebraﬁsh exposed for only a 
20 h period during early embryogenesis (3–23 hpf). (A) The percent of larvae 
showing morphological abnormalities at 168 hpf in larvae exposed to PBDE 
47 (500 and 5000 ng/l). Statistically signiﬁcant differences from control are 
indicated by asterisks (Dunnett’s tests, p < 0.05). Percentages are provided in 
parentheses above each bar, and values are presented as mean ± S.E. (B) The 
most severely impacted larvae (age 164 hpf) exposed to PBDE 47 (5000 fg/l) 
from 3 to 23 hpf exposure developed an abnormal dorsally curved tail, but still 
showed normal inﬂation of the swim bladed (arrows). Scale bar = 1 mm. 
Weiss and Wertman, 1978; Deane and Segal, 1979). However, 
in cases of cardiac dysfunction arising from speciﬁc genetic 
lesions or chemical cardiotoxicity, dorsal curvature is clearly 
preceded by reduction in cardiac output. With PBDE 47 expo­
sure, dorsal curvature preceded the onset of tachycardia, and 
even in early phases of tachycardia (before the development of 
arrhythmia) there were no signs of reduced cardiac output (e.g. 
edema). Moreover, larvae with dorsal curvature due to a pri­
mary cardiac defect do not develop ﬂexion at the hindbrain (see 
Fig. 3F; Incardona et al., 2004, 2006). Instead, the reduced move­
ment of ﬂuorescent dextran through the CSF suggests a primary 
neural defect that leads to altered hydrostatic pressure in the 
CNS. Severe reductions in cardiac output during ﬁsh develop­
ment result in a failure of brain ventricle expansion (Schier et al., 
1996; Lowery and Sive, 2005), while severe reductions in CSF 
ﬂow result in hydrocephaly (Kramer-Zucker et al., 2005). The 
reduced CSF ﬂow in the absence of hydrocephaly in PBDE 47­
exposed larvae suggests that CSF production or secretion may 
be impacted, possibly due to local circulation changes within the 
hindbrain. In this regard, it is notable that PBDE 47-exposed lar­
vae resemble the zebraﬁsh brain mutant turned on, which shows 
a mildly reduced hindbrain ventricle and develops dorsal body 
curvature and ﬂexion at the hindbrain by 6 dpf (Schier et al., 
1996). 
Second, the timing of the cardiac effects of PBDE 47 expo­
sure is consistent with changes in the autonomic regulation of the 
heart. In zebraﬁsh embryos prior to about 72 hpf, cardiac func­
tion (e.g. heart rate, contractility) is driven by intrinsic processes, 
and does not come under extrinsic inﬂuence from autonomic 
input or nitric oxide signaling until later in the larval period 
(Fritsche et al., 2000; Pelster et al., 2005; Schwerte et al., 2006). 
Chemicals that directly impact myocardial targets generally pro­
duce cardiac dysfunction in the range of 24–48 hpf, including 
PAHs (Incardona et al., 2004, 2005, 2006), dioxins (Antkiewicz 
et al., 2005), and cardioactive pharmaceuticals (Langheinrich et 
al., 2003; Milan et al., 2003). Heart rate in zebraﬁsh ﬁrst becomes 
sensitive to externally applied adrenergic agonist at 72 hpf, and 
externally applied acetylcholine at 96 hpf (Schwerte et al., 2006). 
However, the M2 muscarinic acetylcholine receptor is expressed 
in the developing heart by 36 hpf, and morpholino knockdown 
of this receptor produced tachycardia by 72 hpf (Hsieh and Liao, 
2002). Therefore a tachycardia appearing at 96 hpf could result 
from reduced cholinergic input or an excess of adrenergic input. 
PBDE 47 therefore potentially alters the development of the 
vagal or sympathetic inputs to the heart. However, a preliminary 
analysis of islet1-GFP transgenic zebraﬁsh larvae (Higashijima 
et al., 2000) exposed to PBDE 47 showed no gross changes 
in either the vagal innervation of the heart or the distribution of 
vagal motor neuron cell bodies in the hindbrain (data not shown). 
We therefore cannot rule out a neurochemical effect of PBDE 47 
on neurotransmitter levels or receptor activity (either cholinergic 
or adrenergic), a postganglionic effect on the heart (i.e., cardiac 
acetylcholine receptors), or subtle alterations in development of 
autonomic preganglionic ﬁbers, particularly those arising from 
the hindbrain. 
In zebraﬁsh, the thyroid gland differentiates between 40 and 
70 hpf (Rohr and Concha, 2000; Alt et al., 2006) and is func­
tional by 72 hpf (Brown, 1997), but the roles of thyroid hormone 
during zebraﬁsh development are otherwise not well character­
ized. Nevertheless, other than lack of swim bladder inﬂation, 
there is little overlap between the effects of PBDE 47 exposure 
and treatment of zebraﬁsh embryos with goitrogens or the phe­
notype of mutants that lack normal thyroid gland development 
(Liu and Chan, 2002; Elsalini and Rohr, 2003). It is impor­
tant, however, to note that exposure to other thyroid-disrupting 
contaminants (i.e., PCBs) rarely produces effects entirely con­
sistent with genetically mediated or goitrogen-induced thyroid 
hormone deﬁciencies (Brown et al., 2004; Zoeller et al., 2000). 
Therefore, in the absence of speciﬁc assays for thyroid function, 
we cannot rule out an endocrine-disrupting effect of PBDE 47. 
Additional studies are needed to fully identify the mecha­
nisms responsible for the developmental toxicity of PBDE 47. 
Yet by identifying a repeatable suite of morphological and phys­
iological defects caused by PBDE 47 exposure, we now provide 
a starting point for future studies to investigate whether these 
toxic effects result from PBDEs impacting cholinergic function, 
thyroid pathways, or some other physiological mechanism. It is 
likely that considerable insight may be gained by a combination 
of pharmacological studies and a more detailed neuroanatom­
ical analysis, a process that should be greatly enhanced by the 
tools available with the zebraﬁsh model. 
4.2. Relevance to exposure to PBDE contaminants in the 
wild 
In the current study, zebraﬁsh embryos and larvae were 
exposed to PBDE 47 via water, and thus the primary routes 
for PBDE 47 uptake by larvae were likely through the gills into 
blood circulation or through direct dermal absorption. In the 
natural environment, however, PBDEs do not reach high con­
centrations in surface waters due to their high lipophilicity, and 
thus the main route of exposure to PBDEs is likely dietary. The 
lipophilic properties of PBDEs cause them to sequester in lipid-
rich animal tissues. Similar to other lipophilic contaminants such 
as PCBs and DDT, PBDEs have been shown to bioaccumulate 
with increases in trophic level (Law et al., 2003). For juvenile and 
adult ﬁsh, the main exposure route to PBDEs is thus likely to be 
through consumption of PBDE-contaminated prey. At the ear­
liest stages of development, however, maternal-transfer through 
lipid stores of the egg can be a signiﬁcant pathway for embryonic 
exposure to lipophilic contaminants such as PBDEs. 
The concentrations of PBDE 47 required to induce a con­
sistent and reproducible phenotype in zebraﬁsh over this short 
developmental period were high, especially relative to the tissue 
concentrations that have been recorded in people and animals 
in the wild. Using our measured whole-body concentrations of 
PBDE 47 (Table 1) and known whole-body lipid masses for 
larval zebraﬁsh (Petersen and Kristensen, 1998), we calculate 
that the body burden of PBDE 47 in zebraﬁsh larvae from the 
500 fg/l PBDE 47 treatment was ∼2,090,909 ng PBDE 47 g−1 
lipid. In the wild, measurements of PBDE levels in eggs and 
embryos of wildlife are generally lacking. However, some of 
the highest total PBDE levels recorded in adult marine mammals 
(4950 ng PBDE per gram lipid; She et al., 2002), birds (7510 ng 
PBDE per gram lipid; Norstrom et al., 2002), and ﬁshes (7200 ng 
per gram lipid; Hale et al., 2001) (for review, see Hites, 2004) 
are considerably lower than the tissue levels required to cause 
developmental toxicity here. It is important to note, however, 
that this study was a phenotypic screen ofﬁsh embryos exposed 
to a common PBDE congener and was therefore not designed to 
evaluate toxicological responses at low, environmentally real­
istic exposure concentrations. In similar work, Hornung et al. 
(1996) did not observe any toxicity effects of PBDE 47 when 
the compound was injected into rainbow trout (Oncorhynchus 
mykiss) eggs at concentrations up to 12 fg/g, suggesting that 
environmental PBDEs may not yet reach the levels necessary to 
produce developmental defects in wild ﬁsh species. 
Furthermore, we administered only PBDE 47 to develop­
ing ﬁsh embryos since this congener is often the most common 
PBDE compound detected in animal tissues (Hale et al., 2001; 
Brown et al., 2006; Ikonomou et al., 2006; for review, see Hites, 
2004). Animals in the wild, however, are exposed to a suite of 
PBDE forms and other PBDE congeners may be more potent in 
their biological effects. Recent evidence indicates that PBDEs 
can be biotransformed from one congener to another and to 
hydroxylated forms (Kierkegaard et al., 1999; Stapleton et al., 
2004a,b; Tomy et al., 2004), and future work should explore 
whether these hydroxylated PBDEs could in part mediate the 
toxicity of PBDE 47 seen in larval zebraﬁsh. 
5. Conclusions 
Here, we provide the ﬁrst evidence that embryonic exposure 
to PBDE 47 can result in the development of morphological, 
cardiac and neural deﬁcits that impair survivorship for ﬁsh lar­
vae. The concentration of PBDE 47 required to cause acute 
developmental toxicity was considerably higher than the tis­
sue concentrations that have been record in animals and people 
to date. Nevertheless, now that we have identiﬁed consistent 
developmental alterations caused by PBDE 47 exposure, future 
studies have a foundation for exploring the cellular and phys­
iological mechanisms by which PBDE 47 exerts these effects. 
Furthermore, this developmental toxicity was seen in zebraﬁsh at 
high doses of PBDE 47 under controlled laboratory conditions, 
and more work is needed to examine whether similar develop­
mental impacts might occur in native species under long-term 
exposure to lower PBDE concentrations. 
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